Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05687370
Other study ID # YXLL-KY-2022(104)
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2023
Est. completion date March 26, 2023

Study information

Verified date March 2023
Source Qianfoshan Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Conventionally, long-axis in-plane (LA-IP), short-axis out-of-plane (SA-OOP) and dynamic needle tip positioning based on SA-OOP views are commonly used method to image the target vessel during cannulation under US guidance. A modified SA-OOP that add developing line on the ultrasonic probe improve the success rate of cannula insertion into the radial artery on the first attempt.


Recruitment information / eligibility

Status Completed
Enrollment 124
Est. completion date March 26, 2023
Est. primary completion date March 26, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: 1. The diagnostic criteria of coronary atherosclerotic heart disease according to the tenth version of international Classification of diseases(ICD-10); 2. Requires invasive arterial blood pressure monitoring; 3. New York Heart Association(NYHA) classification I, II or III; 4. The American Society of Anesthesiologists (ASA) classification I, II or III; 5. Patients older than 18 years and younger than 85 years (Adult); 6. Patients signed the informed consent before the study. Exclusion Criteria: 1. Patients with hemodynamically unstable (systolic blood pressure 60 or less); 2. Patients with abnormal results of the modified Allen test; 3. Patients with ulnar artery occlusion; 4. Patients with coagulation disorders; 5. Patients with skin abnormalities such as inflammation or hematoma at the cannulation site; 6. Patients with raynaud disease and prevalent atherosclerosis; 7. Patients with history of hand or wrist trauma or surgery; 8. Patients who have undergone radial artery interventional therapy or radial artery cannulation within 3 months on the puncture side; 9. Patients with BMI more than 40 kg/m2; 10. Patients who have participated in other relevant clinical studies within 3 months.

Study Design


Intervention

Procedure:
Modified dynamic needle tip positioning under ultrasound-guidance
The tip of needle is positioned under ultrasound-guidance using modified dynamic short-axis view.
Long-axis technique
The tip of needle is positioned under ultrasound-guidance using conventional long-axis in-plane view.

Locations

Country Name City State
China Shandong Provincial Qianfoshan Hospital Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Qianfoshan Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Success rate of the radial artery cannulation at first attempt Successful confirmation of the arterial waveform through a pressure monitor at first attempt of the radial artery cannulation intraoperative
Secondary Time of arterial catheterization Interval between contact of the ultrasound transducer with the skin and confirmation of an arterial waveform on the monitor, an expected average observation time of 300 seconds
Secondary Time to first puncture of the artery Interval between skin penetration of the needle and flashback of blood, an expected average of 200 seconds
Secondary Time ultrasound imaging Interval between contact of the ultrasound transducer with the skin and penetration of the needle through the skin, , an expected average of 100 seconds
Secondary Number of puncture attempts Up to 5 times, an expected average observation time of 70 seconds
Secondary Vascular complications in the surgery including thrombosis, hematoma, and vasospasm postoperative, within 24 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Coronary De Novo Lesions N/A